Published in Clin Infect Dis on October 19, 2001
Gene expression of the liver in response to chronic hypoxia. Physiol Genomics (2010) 0.94
Ear, nose, and throat effects of high altitude. Eur Arch Otorhinolaryngol (2009) 0.88
High altitude pilgrimage medicine. High Alt Med Biol (2014) 0.75
Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med (1983) 11.15
Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med (1995) 8.89
Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis (1997) 6.64
Enteropathogenic Escherichia coli of classic serotypes associated with infant diarrhea: epidemiology and pathogenesis. Epidemiol Rev (1984) 5.98
Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity. Science (2011) 4.72
Summary of an international workshop on typhoid fever. Rev Infect Dis (1986) 4.21
Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg Infect Dis (1999) 3.38
From the National Institute of Allergy and Infectious Diseases. Summary of a workshop on enteropathogenic Escherichia coli. J Infect Dis (1983) 2.71
Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge. J Infect Dis (1997) 2.55
Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infect Immun (1997) 2.44
Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers. Infect Immun (1992) 2.23
Phenotypic and genotypic characterization of nosocomial Staphylococcus aureus isolates from trauma patients. J Clin Microbiol (1998) 2.22
Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group. Am J Obstet Gynecol (1996) 2.16
Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge. J Infect Dis (1995) 2.10
Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J Infect Dis (1994) 2.03
Vesicular stomatitis virus replication in human leukocyte cultures: enhancement by phytohemagglutinin. Science (1966) 2.03
Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR. J Infect Dis (1992) 1.94
Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae. J Infect Dis (1993) 1.93
High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in The Nile Delta: a pilot study. Am J Trop Med Hyg (1996) 1.86
Complement and C3-proactivator levels in children with protein-calorie malnutrition and effect of dietary treatment. Lancet (1973) 1.79
The epidemiology of acquired immunodeficiency syndrome among heterosexuals. JAMA (1988) 1.78
Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain. Vaccine (1992) 1.69
Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers. Infect Immun (2000) 1.63
Lyme disease ecology in Wisconsin: distribution and host preferences of Ixodes dammini, and prevalence of antibody to Borrelia burgdorferi in small mammals. Am J Trop Med Hyg (1987) 1.59
New evidence for an inflammatory component in diarrhea caused by selected new, live attenuated cholera vaccines and by El Tor and Q139 Vibrio cholerae. Infect Immun (1996) 1.58
Acute medical problems in the Himalayas outside the setting of altitude sickness. High Alt Med Biol (2000) 1.56
Experimental inoculation of Peromyscus spp. with Borrelia burgdorferi: evidence of contact transmission. Am J Trop Med Hyg (1986) 1.55
Mechanisms of defective delayed cutaneous hypersensitivity in children with protein-calorie malnutrition. Lancet (1973) 1.52
Head-injured patients who are nasal carriers of Staphylococcus aureus are at high risk for Staphylococcus aureus pneumonia. Crit Care Med (1999) 1.51
Volunteer studies investigating the safety and efficacy of live oral El Tor Vibrio cholerae O1 vaccine strain CVD 111. Am J Trop Med Hyg (1997) 1.48
Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine. J Infect Dis (1977) 1.44
Specific role of each human leukocyte type in viral infections. 3. 17D yellow fever virus replication and interferon production in homogeneous leukocyte cultures treated with phytohemagglutinin. J Immunol (1969) 1.44
Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system. Infect Immun (1997) 1.43
Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge. Am J Trop Med Hyg (1992) 1.38
Specific role of each human leukocyte type in viral infections. I. Monocyte as host cell for vesicular stomatitis virus replication in vitro. J Virol (1967) 1.37
Specific role of each human leukocyte type in viral infections. II. Phytohemagglutinin-treated lymphocytes as host cells for vesicular stomatitis virus replication in vitro. J Virol (1968) 1.36
Human immunoglobulin M antibody in the sero-diagnosis of Japanese encephalitis virus infections. Am J Epidemiol (1973) 1.36
The active E rosette test: correlation with delayed cutaneous hypersensitivity. J Immunol (1976) 1.36
Persistence of virus-specific IgM and clinical recovery after Japanese encephalitis. Am J Trop Med Hyg (1976) 1.35
Studies of cell-mediated immunity to measles virus by in vitro lymphocyte-mediated cytotoxicity. J Infect Dis (1974) 1.34
Secretory and serum IgA in children with protein-calorie malnutrition. Pediatrics (1975) 1.31
Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg (1993) 1.27
Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres. Vaccine (1994) 1.24
Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults. Infect Immun (2001) 1.23
Validation of a volunteer model of cholera with frozen bacteria as the challenge. Infect Immun (1998) 1.23
Classification of HTLV-III/LAV-related diseases. J Infect Dis (1985) 1.22
Study of Japanese encephalitis virus in Chiangmai Valley, Thailand. 3. Human seroepidemiology and inapparent infections. Am J Epidemiol (1973) 1.22
Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge. J Clin Invest (1992) 1.21
Immunoglobulin response and viremia in dengue-vaccinated gibbons repeatedly challenged with Japanese encephalitis virus. Am J Epidemiol (1973) 1.18
Vaccine adjuvants. Rev Infect Dis (1980) 1.17
Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C. Clin Immunol (2000) 1.14
The active E-rosette test: a sensitive in vitro correlate for human delayed-type hypersensitivity. J Immunol (1977) 1.12
Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes. J Infect Dis (2000) 1.12
Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device. Vaccine (1999) 1.12
Hepatitis c and cirrhotic liver disease in the Nile delta of Egypt: a community-based study. Am J Trop Med Hyg (2001) 1.11
Active surveillance for respiratory virus infections in adults who have undergone bone marrow and peripheral blood stem cell transplantation. Bone Marrow Transplant (2003) 1.10
CD4+ T cell clones obtained from Plasmodium falciparum sporozoite-immunized volunteers recognize polymorphic sequences of the circumsporozoite protein. J Immunol (1993) 1.09
Influence of the degree of metabolic control on physical fitness in type I diabetic adolescents. Int J Sports Med (1986) 1.07
Determination of regional pulmonary parenchymal strain during normal respiration using spin inversion tagged magnetization MRI. J Magn Reson Imaging (2001) 1.06
Acute diarrheal infections in infants I. Bacterial and viral causes. Hosp Pract (1980) 1.03
Enhancement of replication of vesicular stomatitis virus in human lymphocyte cultures treated with heterologous anti-lymphocyte serum. Lancet (1968) 1.02
Dissemination of antibiotic-resistant bacteria across geographic borders. Clin Infect Dis (2001) 1.00
Cytotoxic CD4+ T cells from a sporozoite-immunized volunteer recognize the Plasmodium falciparum CS protein. Int Immunol (1991) 1.00
Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru. Infect Immun (1997) 0.99
Evaluation in humans of a new, inactivated vaccine for Venezuelan equine encephalitis virus (C-84). J Infect Dis (1979) 0.98
The epidemiology of antibody to hepatitis C in Egypt. J Infect Dis (1993) 0.98
Safety and immunogenicity of a recombinant sporozoite malaria vaccine against Plasmodium vivax. Am J Trop Med Hyg (1991) 0.98
Extension of the volunteer challenge model to study South American cholera in a population of volunteers predominantly with blood group antigen O. Trans R Soc Trop Med Hyg (1995) 0.97
Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21. Vaccine (2001) 0.96
Dengue virus-specific, human CD4+ cytotoxic T lymphocytes generated in short-term culture. Viral Immunol (1993) 0.95
Characterization of the human hepatocellular carcinoma (hepg2) cell line as an in vitro model for cadmium toxicity studies. In Vitro Cell Dev Biol Anim (2004) 0.95
Phase 1 studies of Walter Reed Army Institute of Research candidate attenuated dengue vaccines: selection of safe and immunogenic monovalent vaccines. Am J Trop Med Hyg (2003) 0.95
Epidemiology of capsular and surface polysaccharide in Staphylococcus aureus infections complicated by bacteraemia. J Hosp Infect (2005) 0.95
Plasma kallikrein activation and inhibition during typhoid fever. J Clin Invest (1978) 0.94
Incidence and cumulative frequency of endemic Lyme disease in a community. J Infect Dis (1984) 0.94
Ultra sonographic measurements of the normal liver and spleen among Egyptians 10-50 years old. J Egypt Public Health Assoc (1997) 0.94
Immunoglobulins and antibody response in children with protein-calorie malnutrition. Am J Clin Nutr (1976) 0.94
Safety, immunogenicity, and efficacy of a malaria sporozoite vaccine administered with monophosphoryl lipid A, cell wall skeleton of mycobacteria, and squalane as adjuvant. Am J Trop Med Hyg (1994) 0.93
Lack of prophylactic efficacy of an enteric-coated bovine hyperimmune milk product against enterotoxigenic Escherichia coli challenge administered during a standard meal. J Infect Dis (1999) 0.91
Study of Japanese encephalitis virus in Chiangmai valley, Thailand. II. Human clinical infections. Am J Epidemiol (1973) 0.91
Serologic responses and systemic reactions in adults after vaccination with bivalent A/Victoria/75-A/New Jersey/76 and monovalent B/Hong Kong/72 influenza vaccines. J Infect Dis (1977) 0.91
Initial safety and immunogenicity studies of an oral recombinant adenohepatitis B vaccine. Vaccine (1992) 0.91
Clinical sequelae after japanese encephalitis: a one year follow-up study in Thailand. Southeast Asian J Trop Med Public Health (1974) 0.90
Acute diarrheal infections in infants. I. Epidemiology, Treatment, and prospects for immunoprophylaxis. Hosp Pract (1979) 0.89
Interaction of alphaviruses with human peripheral leukocytes: in vitro replication of Venezuelan equine encephalomyelitis virus in monocyte cultures. Infect Immun (1979) 0.89
Evaluation of the plasma kinin system in dengue hemorrhagic fever. J Lab Clin Med (1975) 0.89
Future vaccines against enteric pathogens. Infect Dis Clin North Am (1990) 0.89
Cortical activation in the human brain during lateral saccades using EPISTAR functional magnetic resonance imaging. Neuroimage (1996) 0.88
Study of Japanese encephalitis virus in Chiangmia Valley, Thailand. VI. Summary and conclusions. Am J Epidemiol (1974) 0.88
A simple, quantitative, reproducible avidin-biotin ELISA for the evaluation of group B streptococcus type-specific antibodies in humans. Vaccine (1996) 0.88
Chicken-induced anaphylactoid reaction and colitis. J Pediatr Gastroenterol Nutr (1994) 0.87
Safety and immunogenicity in volunteers of a recombinant Plasmodium falciparum circumsporozoite protein malaria vaccine produced in Lepidopteran cells. Vaccine (1992) 0.87
T cell responses to repeat and non-repeat regions of the circumsporozoite protein detected in volunteers immunized with Plasmodium falciparum sporozoites. Mem Inst Oswaldo Cruz (1992) 0.87
Study of Japanese encephalitis virus in Chiangmai Valley, Thailand. IV. Vector studies. Am J Epidemiol (1974) 0.86
Tuberous sclerosis in the fetus: second-trimester diagnosis of subependymal tubers with ultrafast MR imaging. AJR Am J Roentgenol (2000) 0.86
Atypical antibody responses in dengue vaccine recipients. Am J Trop Med Hyg (2003) 0.84